Evidence map›Paper›PMID 37564651›Full record

ArticleFrontiers in immunology2023

Transcriptomic profile of

Paolo Marzano, Simone Balin, Sara Terzoli, Silvia Della Bella, Valentina Cazzetta, Rocco Piazza, Inga Sandrock, Sarina Ravens, Likai Tan, Immo Prinz and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Paolo MarzanoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Simone BalinDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Sara TerzoliLaboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Silvia Della BellaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Valentina CazzettaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Rocco PiazzaDepartment of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Inga SandrockInstitute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Sarina RavensInstitute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Likai TanInstitute of Systems Immunology, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Immo PrinzInstitute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Francesca CalcaterraDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Clara Di VitoLaboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Assunta CancellaraDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Michela CalviDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Anna CarlettiLaboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Sara FranzeseDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Alessandro FrigoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Ahmed DarwishDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Antonio VozaDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.
Joanna MikulakLaboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Domenico MavilioDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
IRCCS Humanitas Research Hospital · ITUniversity of Milan · ITMedizinische Hochschule Hannover · DEHumanitas University · ITUniversity Medical Center Hamburg-Eppendorf · DEUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Higher frequencies of mucosal-associated invariant T (MAIT) cells were associated with an increased adaptive response to mRNA Methods: To investigate the effects of repeated SARS-CoV-2 vaccinations on the peripheral blood mononuclear cells (PBMCs), we performed a longitudinal single cell (sc)RNA-seq and scTCR-seq analysis of SARS-CoV-2 vaccinated healthy adults with two doses of the Pfizer-BioNTech Results: We identified MAIT cells as an important source of TNF across circulating lymphocytes in response to repeated SARS-CoV-2 Discussion: Overall, our results indicate that SARS-CoV-2

Indexed as

COVID-19Mucosal-Associated Invariant T CellsAdultBNT162 VaccineCOVID-19 VaccinesHumansLeukocytes, MononuclearSARS-CoV-2TranscriptomeVaccinationBNT162 VaccineCOVID-19 VaccinesB cellsimmune responseMAIT cellsmRNA vaccineSARS-CoV-2single-cell RNA/TCR-sequencingTNF

Identifiers

PMID37564651
PMCPMC10410451
OpenAlexW4385272105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.